BILLERICA, Mass.--(BUSINESS WIRE)--Bruker BioSciences Corporation (Nasdaq: BRKR) today announced that it has priced a public offering of 10,400,000 shares of its common stock, 2,200,000 of which are being sold by the Company and 8,200,000 of which are being sold by four selling stockholders, at $7.10 per share, generating net proceeds of approximately $14.7 million to the Company and approximately $54.9 million to the selling stockholders, in the aggregate. The Company has granted the underwriters an option to purchase up to an additional 330,000 shares of common stock and the selling stockholders have granted the underwriters an option to purchase up to an additional 1,230,000 shares of common stock to cover over-allotments, if any, which would generate additional net proceeds to the Company of approximately $2.2 million and additional net proceeds to the selling stockholders of approximately $8.3 million, if exercised in full.
